Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
11 /100
LOW RISK
Score updated Oct 13, 2026

TXG — 10x Genomics, Inc. Dilution Risk Tracker

Track TXG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TXG — Get alerts when the score changes →

As of October 13, 2026, 10x Genomics, Inc. (TXG) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. 10x Genomics, Inc. has a market capitalization of $9.60B, 127.69M shares outstanding, 337 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway—
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TXG.
🔔 Track TXG — Get forecast alerts →

Market Data

Market Cap$9.60B
Shares Outstanding127.69M
Float115.09M
Cash$344.07M
Debt$81.39M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore11/100DilutionWatch score record
Shares Outstanding127.69MVerified float table or market cache
Public Float115.09MVerified float table or market cache
Market Cap$9.60BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: FORM 4 5.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 12.8% shares (2026Q1 vs prior)
337 institutional holders · 146.28M shares
#1 FMR LLC 17.74M shares
#2 ARK Investment Management LLC 11.72M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 10.54M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest15.37M
Days to Cover4.5
% of Float13.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

Form 4 INSIDER TRANSACTION 2026-09-22
Form 4 INSIDER TRANSACTION 2026-09-22
Form 4 INSIDER TRANSACTION 2026-09-22
Form 4 INSIDER TRANSACTION 2026-09-22
Form 4 INSIDER TRANSACTION 2026-09-22
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TXG Dilution Snapshot

10x Genomics, Inc. (TXG) has a DilutionScore of 11/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TXG's DilutionScore has held steady at 11/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202611/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TXG shares outstanding have decreased 0.7% from 117.67M (Mar 2026) to 116.88M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 12, 2026116.88M115.09M▼ 0.16%
May 11, 2026118.91M115.27M▼ 1.04%
May 10, 2026118.91M116.49M▲ 0.42%
May 04, 2026118.91M116.00M▲ 0.10%
Apr 28, 2026118.91M115.88M▲ 0.34%
Apr 26, 2026117.67M115.49M▲ 0.14%
Apr 17, 2026117.67M115.32M▲ 0.01%
Apr 11, 2026117.67M115.31M▲ 0.01%
Mar 09, 2026117.67M115.30M▼ 0.16%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TXG Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TXG files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TXG — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TXG
TXG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.